Deals Rumor Mill: Amgen, Newfield, Verizon
Amgen Inc.'s $9.5 billion takeover of rival Onyx Pharmaceuticals Inc. is being held up as the two lock horns over access to data from an ongoing clinical trial of one of...To view the full article, register now.
Already a subscriber? Click here to view full article